Published in J Natl Cancer Inst Monogr on May 01, 2012
Introduction: Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr (2012) 2.15
State-of-the-art and future directions in multilevel interventions across the cancer control continuum. J Natl Cancer Inst Monogr (2012) 1.30
Multilevel intervention research: lessons learned and pathways forward. J Natl Cancer Inst Monogr (2012) 1.16
Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges. Genet Med (2013) 0.86
What is translational genomics? An expanded research agenda for improving individual and population health. Appl Transl Genom (2014) 0.84
Beyond public health genomics: proposals from an international working group. Eur J Public Health (2014) 0.83
Integrating genetic and genomic information into effective cancer care in diverse populations. Ann Oncol (2013) 0.78
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? Curr Hematol Malig Rep (2015) 0.77
Multilevel intervention research applications in cancer care delivery. J Natl Cancer Inst Monogr (2012) 0.77
Do physicians think genomic medicine will be useful for patient care? Per Med (2015) 0.76
Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations. Genet Med (2016) 0.75
Participatory epidemiology: the contribution of participatory research to epidemiology. Emerg Themes Epidemiol (2017) 0.75
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine. Healthcare (Basel) (2016) 0.75
The front line of genomic translation. J Cancer Epidemiol (2012) 0.75
Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA (1999) 40.60
Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q (2004) 34.12
Electronic health records in ambulatory care--a national survey of physicians. N Engl J Med (2008) 17.18
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA (2003) 14.72
Use of electronic health records in U.S. hospitals. N Engl J Med (2009) 14.36
Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res (2004) 13.91
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48
Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10
Development and testing of a short form of the patient activation measure. Health Serv Res (2005) 8.26
The role of patient care teams in chronic disease management. BMJ (2000) 7.17
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Errors in laboratory medicine. Clin Chem (2002) 4.87
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Genomics and drug response. N Engl J Med (2011) 4.35
Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA (2008) 4.01
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65
The evidence dilemma in genomic medicine. Health Aff (Millwood) (2008) 3.58
Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med (2006) 3.54
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Genomic medicine--an updated primer. N Engl J Med (2010) 3.48
Benefits of and barriers to large medical group practice in the United States. Arch Intern Med (2003) 3.45
Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem (2007) 3.23
Clinically relevant changes in family history of cancer over time. JAMA (2011) 3.18
How good is the quality of health care in the United States? 1998. Milbank Q (2005) 3.08
Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof (2007) 2.92
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.53
Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med (2003) 2.50
Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health (2010) 2.43
Genomics and the continuum of cancer care. N Engl J Med (2011) 2.26
Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol (2006) 2.24
Mixed results in the safety performance of computerized physician order entry. Health Aff (Millwood) (2010) 2.19
Introduction: Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr (2012) 2.15
From understanding health care provider behavior to improving health care: the QUERI framework for quality improvement. Quality Enhancement Research Initiative. Med Care (2000) 2.12
Implementing practical interventions to support chronic illness self-management. Jt Comm J Qual Saf (2003) 2.08
Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med (2008) 2.02
Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials. Diabetes Care (2009) 1.88
Empowering primary care health professionals in medical genetics: how soon? How fast? How far? Am J Med Genet (2001) 1.86
Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol (2007) 1.77
American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. J Clin Oncol (2008) 1.75
Preparing for a consumer-driven genomic age. N Engl J Med (2010) 1.72
Cottage industry to postindustrial care--the revolution in health care delivery. N Engl J Med (2010) 1.69
Targeting the function of the HER2 oncogene in human cancer therapeutics. Oncogene (2007) 1.69
Recommendations for client- and provider-directed interventions to increase breast, cervical, and colorectal cancer screening. Am J Prev Med (2008) 1.67
Translational research in cancer genetics: the road less traveled. Public Health Genomics (2009) 1.65
Information system support as a critical success factor for chronic disease management: Necessary but not sufficient. Int J Med Inform (2006) 1.54
Ten years on--the human genome and medicine. N Engl J Med (2010) 1.52
Dealing with the evidence dilemma in genomics and personalized medicine. Clin Pharmacol Ther (2010) 1.43
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med (2011) 1.37
Multilevel factors affecting quality: examples from the cancer care continuum. J Natl Cancer Inst Monogr (2012) 1.37
Horizon scanning for new genomic tests. Genet Med (2011) 1.36
Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes (2004) 1.36
Risks of presymptomatic direct-to-consumer genetic testing. N Engl J Med (2010) 1.36
In search of synergy: strategies for combining interventions at multiple levels. J Natl Cancer Inst Monogr (2012) 1.35
State-of-the-art and future directions in multilevel interventions across the cancer control continuum. J Natl Cancer Inst Monogr (2012) 1.30
Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep (2000) 1.27
Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine. Genet Med (2009) 1.26
Predictive genetic testing for type 2 diabetes. BMJ (2006) 1.24
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep (2004) 1.23
Practice guidelines: best hope for quality improvement in the 1990s. J Occup Med (1990) 1.20
Lynch syndrome screening implementation: business analysis by a healthcare system. Am J Manag Care (2011) 1.19
The state of the medical geneticist workforce: findings of the 2003 survey of American Board of Medical Genetics certified geneticists. Genet Med (2005) 1.18
Redesigning health systems for quality: Lessons from emerging practices. Jt Comm J Qual Patient Saf (2006) 1.15
The role of organizational research in implementing evidence-based practice: QUERI Series. Implement Sci (2008) 1.11
Implant vendors and hospitals: competing influences over product choice by orthopedic surgeons. Health Care Manage Rev (2008) 1.11
The gap between practice and genetics education of health professionals: HuGEM survey results. Genet Med (2001) 1.04
Computational modeling and multilevel cancer control interventions. J Natl Cancer Inst Monogr (2012) 1.02
Lessons from implementing a combined workflow-informatics system for diabetes management. J Am Med Inform Assoc (2008) 0.98
Development of communities of practice to facilitate quality improvement initiatives in surgical oncology. Qual Manag Health Care (2008) 0.97
Genetics of common disease: a primary care priority aligned with a teachable moment? Genet Med (2008) 0.92
Recommendations to improve targeted vaccination coverage among high-risk adults. Am J Prev Med (2005) 0.91
Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol (2009) 0.90
Age and rural residence effects on accessing colorectal cancer treatments: a registry study. Am J Manag Care (2010) 0.90
Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann Oncol (2008) 0.90
Errors in laboratory medicine and patient safety: the road ahead. Clin Chem Lab Med (2007) 0.88
Dealing with innovation and costs in orthopedics: a conversation with Dane Miller. Interview by Lawton R Burns. Health Aff (Millwood) (2006) 0.87
Standardizing care in medical oncology: are Web-based systems the answer? Cancer (2009) 0.86
Disparity in cancer survival between urban and rural patients--how can clinicians help reduce it? Rural Remote Health (2009) 0.85
The effect of HEDIS measurement of colorectal cancer screening on insurance plans in Pennsylvania. Am J Manag Care (2008) 0.84
Who should have genetic testing for the Lynch syndrome? Ann Intern Med (2011) 0.83
Market entry and exit by biotech and device companies funded by venture capital. Health Aff (Millwood) (2008) 0.83
Experience with Medicare's new technology add-on payment program. Health Aff (Millwood) (2008) 0.80
Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study. Fam Cancer (2011) 0.79
Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment. Fam Cancer (2011) 0.78
Keys to a high-performance health system for the United States. Healthc Financ Manage (2006) 0.78
Partner support and distress in women with breast cancer: The role of patients' awareness of support and level of mastery. Psychol Health (2009) 0.76
Assessment of medical devices: how to conduct comparative technology evaluations of product performance. Int J Technol Assess Health Care (2007) 0.76
The total testing process and its implications for laboratory administration and education. Clin Lab Manage Rev (1994) 0.76
Electronic medical records: oncology practices take the plunge. J Natl Cancer Inst (2009) 0.76
Management of young onset colorectal cancer: divergent practice in the East of England. Colorectal Dis (2011) 0.76
Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer. J Am Acad Nurse Pract (2011) 0.76
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof (2006) 8.25
Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer (2003) 6.92
The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health (2009) 6.75
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health Serv Res (2002) 5.10
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med (2002) 4.34
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf (2008) 3.26
A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am J Prev Med (2011) 3.24
Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care (2009) 3.16
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Do Internet-based support interventions change perceptions of social support?: An experimental trial of approaches for supporting diabetes self-management. Am J Community Psychol (2002) 3.06
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 3.05
External validity: we need to do more. Ann Behav Med (2006) 3.05
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Motivation to quit using cigarettes: a review. Addict Behav (2006) 2.77
Dissemination and implementation research on community-based cancer prevention: a systematic review. Am J Prev Med (2010) 2.76
Increasing diabetes self-management education in community settings. A systematic review. Am J Prev Med (2002) 2.75
Beginning with the application in mind: designing and planning health behavior change interventions to enhance dissemination. Ann Behav Med (2005) 2.69
What does it mean to "employ" the RE-AIM model? Eval Health Prof (2012) 2.57
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implement Sci (2013) 2.51
Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer (2004) 2.38
Review of external validity reporting in childhood obesity prevention research. Am J Prev Med (2008) 2.33
Development of a brief diabetes distress screening instrument. Ann Fam Med (2008) 2.30
Considerations for diabetes translational research in real-world settings. Diabetes Care (2003) 2.26
Ecological approaches to self-management: the case of diabetes. Am J Public Health (2005) 2.23
Behavior change intervention research in community settings: how generalizable are the results? Health Promot Int (2004) 2.22
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
A Framework for Enhancing the Value of Research for Dissemination and Implementation. Am J Public Health (2015) 2.19
A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing. Pharmacoeconomics (2010) 2.19
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
Introduction: Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr (2012) 2.15
The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control (2009) 2.14
Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med (2010) 2.12
Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care (2008) 2.11
Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med (2013) 2.10
Work site health promotion research: to what extent can we generalize the results and what is needed to translate research to practice? Health Educ Behav (2003) 2.10
Separate and unequal: racial segregation and disparities in quality across U.S. nursing homes. Health Aff (Millwood) (2007) 2.09
Applying the RE-AIM framework to assess the public health impact of policy change. Ann Behav Med (2007) 2.06
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med (2008) 2.05
Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol (2015) 2.04
Partnership research: a practical trial design for evaluation of a natural experiment to improve depression care. Med Care (2010) 2.02
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med (2008) 2.02
Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 2.01
Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med (2012) 1.98
Understanding high-quality cancer care: a summary of expert perspectives. Cancer (2008) 1.97
The RE-AIM framework: a systematic review of use over time. Am J Public Health (2013) 1.96
Organising care for chronic illness. BMJ (2002) 1.95
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
RE-AIM: evidence-based standards and a Web resource to improve translation of research into practice. Ann Behav Med (2004) 1.93
The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care (2010) 1.89
Reaching those most in need: a review of diabetes self-management interventions in disadvantaged populations. Diabetes Metab Res Rev (2002) 1.89
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab (2014) 1.88
Harmonized patient-reported data elements in the electronic health record: supporting meaningful use by primary care action on health behaviors and key psychosocial factors. J Am Med Inform Assoc (2012) 1.87
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84
Geographic concentration and correlates of nursing home closures: 1999-2008. Arch Intern Med (2011) 1.83
The U.S. training institute for dissemination and implementation research in health. Implement Sci (2013) 1.83
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med (2011) 1.80
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
Making evidence from research more relevant, useful, and actionable in policy, program planning, and practice slips "twixt cup and lip". Am J Prev Med (2009) 1.78
Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions. J Gen Intern Med (2007) 1.78
Physical activity promotion through primary care. JAMA (2003) 1.75
Understanding the context of health for persons with multiple chronic conditions: moving from what is the matter to what matters. Ann Fam Med (2014) 1.73
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol (2014) 1.73
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev (2013) 1.72
Use of chronic care model elements is associated with higher-quality care for diabetes. Ann Fam Med (2007) 1.68
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Computer-assisted intervention improves patient-centered diabetes care by increasing autonomy support. Health Psychol (2007) 1.63
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer (2002) 1.62
Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology (2009) 1.61
Crossing the omic chasm: a time for omic ancillary systems. JAMA (2013) 1.59
Methodologic challenges in disseminating evidence-based interventions to promote physical activity. Am J Prev Med (2006) 1.59
The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care (2005) 1.58
Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol (2007) 1.58
Behavior matters. Am J Prev Med (2011) 1.58
Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program. Implement Sci (2009) 1.55
Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med (2004) 1.55
Overview of the SEER--Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev (2008) 1.55
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med (2013) 1.55
Knowledge integration at the center of genomic medicine. Genet Med (2012) 1.54
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn (2009) 1.54
Biologic and quality-of-life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care (2003) 1.52
Electronic medical records and personalized medicine. Hum Genet (2011) 1.52
Self-efficacy, problem solving, and social-environmental support are associated with diabetes self-management behaviors. Diabetes Care (2010) 1.51
The frequency and behavioral outcomes of goal choices in the self-management of diabetes. Diabetes Educ (2005) 1.51
The future of physical activity behavior change research: what is needed to improve translation of research into health promotion practice? Exerc Sport Sci Rev (2004) 1.50